Weatherbie Specialized Growth Fund Q3 2026 Portfolio Update

Natera reported stronger-than-expected results and raised its full-year outlook. Impinj delivered stronger-than-expected results, with record revenue and profitability, while Hamilton Lane shares contributed positively during the quarter after the company reported revenue and earnings above expectations.

Analysis

The shared signal is earnings delivery, not a common macro theme: the three companies monetize different drivers, so do not treat this as confirmation of broad risk-on or a single sector trend. The key question is whether beats came from durable volume, pricing and recurring revenue—or timing, mix and expense control. Without company-level metrics, the positive reaction is not enough to underwrite estimate revisions.

For Natera, sustained test adoption only translates into durable value if reimbursement, collections and evidence support keep pace; reimbursement friction or stronger competing offerings from Exact Sciences and Guardant Health could limit conversion. For Impinj, record performance could pull forward RFID demand: retailers and logistics users benefit from better inventory visibility, but a tag/reader replenishment cycle would make the upside vulnerable to customer inventory normalization and component availability. For Hamilton Lane, stronger results need to be separated into recurring management fees versus realization-sensitive income; private-market fundraising and distributions are the relevant medium-term checks, not one quarter’s share contribution.

Days: positive earnings reactions may extend, but the article gives no surprise magnitude or valuation context. Over 1–3 months, watch guidance revisions, demand/reimbursement indicators, and private-market fundraising/distributions. Over 6–18 months, the distinction between structural adoption and cyclical pull-forward should dominate. Contrarian risk: investors may extrapolate three unrelated beats; conversely, if results reflect recurring demand and estimates continue rising, the initial reaction may understate earnings durability.

Key Decisions for Investors

• Do not buy the three names as a basket on this item alone. Before adding, verify beat composition, forward guidance versus prior expectations, and post-report estimate revisions; those data are absent here.
• PI: place on a pullback-entry watch rather than chase the reaction. Consider a tactical long only if subsequent updates confirm broad end-market demand and customer inventories remain healthy; reverse the thesis if guidance or order commentary signals replenishment has peaked.
• NTRA: require confirmation that test growth is converting into collections and durable reimbursement before adding. Track payer coverage and utilization; evidence of weaker reimbursement or slowing adoption would falsify the positive read-through.
• HLNE: monitor recurring fee-related earnings, fundraising and realizations separately. Avoid extrapolating a quarter’s contribution if results rely disproportionately on realizations; weakening fundraising or distributions would argue against the thesis.